The DOI matches its Crossref record; 112 of the 115 references it cites were found in a registry or an index.
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Open accessAbstract
One-fourth of all deaths in industrialized countries result from coronary heart disease. A century of research has revealed the essential causative agent: cholesterol-carrying low-density lipoprotein (LDL). LDL is controlled by specific receptors (LDLRs) in liver that remove it from blood. Mutations that eliminate LDLRs raise LDL and cause heart attacks in childhood, whereas mutations that raise LDLRs reduce LDL and diminish heart attacks. If we are to eliminate coronary disease, lowering LDL should be the primary goal. Effective means to achieve this goal are currently available. The key questions are: who to treat, when to treat, and how long to treat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The receptors for LDL (LDLR) and transferrin receptor (TFR) are both endocytosed from the cell surface via clathrin-coated vesicles and transported through intracellular recycling pathways (14, 15, 16, 17, 18, 19, 20).”
From The small GTPase RAB10 regulates endosomal recycling of the LDL receptor and transferrin receptor in hepatocytes (2022) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LDLR plays a crucial role in the uptake of LDL-C from the circulation by hepatocytes 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“The regulation of LDLR trafficking and turnover is essential for maintaining cholesterol homeostasis and remains a major focus of therapeutic strategies for CVD 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Elevated LDL-C levels are linked to an increased risk of ASCVD,4,5”
From Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation (2025) · cites this paper as [5]
In the citing paper
“Unlike common diseases, the clarity of causation for Mendelian disorders usually simplifies the task of generating models (including human cells and organoids or rodents) to connect genotype to organismal phenotype; these have led to many critical insights into the biology of health and disease in humans98,99.”
From A brief history of human disease genetics (2020) · cites this paper as [98]
In the citing paper
“These data suggest that lifelong lower levels of plasma LDL cholesterol are much more effective than late LDL reductions induced by statins in preventing coronary heart disease (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
In the citing paper
“Hypercholesterolemia is one of the key risk factors in promoting atherosclerosis, which is the underlying cause of approximately 90% of cases of myocardial infarction, 60% of strokes, most cases of chronic heart failure, peripheral arterial disease, and vascular dementia (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
In the citing paper
“An example is the J-shaped association between alcohol consumption and cardiovascular disease; there is now consensus that this apparent protective effect of moderate levels of consumption is artefactual, as discussed above.130”
From Mendelian randomization (2022) · cites this paper as [130]
In the citing paper
“For example, a large-effect genetic variant influencing alcohol consumption that has been of considerable value in MR studies of the effects of alcohol75,130 is only prevalent in East Asian populations.”
From Mendelian randomization (2022) · cites this paper as [130]
In the citing paper
“Mutations in LDLR cause familial hypercholesterolemia (FH), characterized by elevated levels of plasma LDL-C and increased risk of coronary heart disease (1).”
From Identification of amino acid residues in the MT-loop of MT1-MMP critical for its ability to cleave low-density lipoprotein receptor (2022) · cites this paper as [1]
In the citing paper
“Statins block cholesterol synthesis by suppressing HMG-CoA reductase91”
From EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis (2025) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citation(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Self-citationSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citationProgress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Self-citation
Flagged first, then by citations
3 of the 115 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Anitschkow, 1913, Ueber experimentelle cholesterinsteatose und ihre bedeutung für die entstehung einiger pathologischer prozesse, Zentralbl. Allg. Pathol. Anat., 24, 1
- Goldstein, 1982, Lipoprotein receptors: Genetic defense against atherosclerosis, Clin. Res., 30, 417
Cited by
Sorted by citations
Items 801–900 of 1,000
Ibraheem, O., Ibikunle, P. D., Gabriel-Ajobiewe, R. A., Oyeniran, O. H., Sodipe, G. O., Komolafe, T. R., Komolafe, K., Oyewole, O. T., Ogwa, E. C., & Jeje, T. O. (2025) · Journal of Food Science · doi:10.1111/1750-3841.70446 · Cited by 3
Cholesterol homeostasis and pathway enrichment in post-revascularization recovery
Basit, S. A., Alajez, N. M., & Alam, T. (2025) · BioMedical Engineering OnLine · doi:10.1186/s12938-025-01429-x · Cited by 3
Rahaman, M. M., Wangchuk, P., & Sarker, S. (2025) · Scientifica · doi:10.1155/sci5/3367875 · Cited by 5
The association between skipping breakfast and cardiovascular disease: a meta analysis
Zhang, H., Zhang, S., Liu, Y., Wang, X., & Hu, J. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1565806 · Cited by 3
Hu, X., Zhao, Y., Guan, Q., Zhong, H., Yang, Y., Chen, Y., Fan, W., Ye, X., Qiu, X., Huang, S., et al. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.01.006 · Cited by 3
Durrington, P. N., Bashir, B., & Soran, H. (2026) · Springer eBooks · doi:10.1007/978-3-031-96019-2_35 · Cited by 3
Regulatory roles of bioactive lipids in vascular homeostasis and remodeling
Yang, J., Xiao, H., Zhang, Z., Zhang, L., & Zhang, X. R. (2026) · Medical Review · doi:10.1515/mr-2025-0073 · Cited by 3
Fan, X., Wei, Y., Zhao, J., Wang, Y., Zhao, J., & Xu, Q. (2026) · Fishes · doi:10.3390/fishes11040204 · Cited by 3
He, T., Fang, X., Zhu, L., Fan, H., Qiu, Y., Zhou, L., & Jiang, S. (2026) · Small · doi:10.1002/smll.73301 · Cited by 3
Molinari, M., Cremaschi, A., Iorio, M. D., Chaturvedi, N., Hughes, A. D., & Tillin, T. (2022) · Journal of Applied Statistics · doi:10.1080/02664763.2022.2116746 · Cited by 3
Tran, D. T., & Dahlin, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-39094-4_5 · Cited by 4
Wang, L., Lin, M. T., Li, K., Wang, L., Wang, Y., & Yang, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s478526 · Cited by 3
Ma, C.-I. J., Steinfeld, N., Wang, W. A., & Maxfield, F. R. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00675 · Cited by 3
Lin, Y., Liu, X., Ren, B., Wang, J., Li, Y., Liu, X., Wang, Y., Xiao, F., & Mu, S. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00808-9 · Cited by 3
Zhang, X., Rimbert, A., Balder, W., Zwinderman, A. H., Kuivenhoven, J. A., Dallinga‐Thie, G. M., & Groen, A. K. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m088930 · Cited by 3
Tedgui, A. (2019) · médecine/sciences · doi:10.1051/medsci/2019123 · Cited by 3
Chua, N. K., & Brown, A. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_583 · Cited by 3
Nasution, M. A. F., Riyanto, H. G., Saepudin, E., & Ivandini, T. A. (2020) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/902/1/012017 · Cited by 3
The Role of Statins in Prevention of Cardiovascular Diseases in Real Clinical Practice
IuA, K., & Moscow, R. F. (2021) · Doctor Ru · doi:10.31550/1727-2378-2021-20-11-17-27 · Cited by 4
Statins in Alcoholic and Non-Alcoholic Fatty Liver Disease and Chronically Elevated Liver Enzymes
Aishwarya, A., & Oroszi, T. L. (2022) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2022.137020 · Cited by 3
Production of Lovastatin and its Lipid-lowering and Anti-Cancer Effects
Du, Y., Liu, Y., & Zheng, Y. (2022) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v11i.1386 · Cited by 3
Khan, M. I., Zhang, Q., Tian, Y., Saud, S., Cao, Y., Ren, J., Liu, W., & Cao, C. (2023) · Analytical Methods · doi:10.1039/d3ay00550j · Cited by 3
Rebitzer, J. B., & Rebitzer, R. S. (2023) · doi:10.1093/oso/9780197603109.001.0001 · Cited by 3
Hanse, M., Akbar, S., Layeghkhavidaki, H., & Yen, F. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216298 · Cited by 3
Veronese, N., Burgio, M. I., Mandalà, C., Saguto, D., Dominguez, L. J., Barbagallo, M., Smith, L., Fontana, L., Lip, G. Y. H., & Prokopidis, K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102645 · Cited by 5
IDOL Deficiency Inhibits Cholesterol-Rich Diet–Induced Atherosclerosis in Rabbits
Koike, T., Koike, Y., Niimi, M., Guo, Y., Yang, D., Song, J. W., Xu, J., Tang, X., Ren, Z., Kong, X., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322417 · Cited by 3
Zhao, T., Xu, L., Ge, Z., Shi, J., Wang, T., Zhang, J., Zhang, X., Jiang, H., Zhou, L., & Ye, L. (2025) · Toxicology · doi:10.1016/j.tox.2025.154216 · Cited by 3
Köseler, A., Arslan, İ., Sabırlı, R., Zeytünlüoğlu, A., Kılıç, O., & Kılıç, İ. D. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0468 · Cited by 3
Processing and Degradation of Cellular Components
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-34126-4.00023-2 · Cited by 3
Cholesterol: the debate should be terminated
Nathan, D. G. (2017) · The FASEB Journal · doi:10.1096/fj.201700385r · Cited by 3
Lost in Menopausal Transition: the Timing of Atherosclerosis Prevention in Women
Pitha, J. V. (2017) · Physiological Research · doi:10.33549/physiolres.933582 · Cited by 3
Weir (2020) · The Journal of Family Practice · doi:10.12788/jfp.0068 · Cited by 3
Recognition and Management of Hypoglycemia
Shubrook (2020) · The Journal of Family Practice · doi:10.12788/jfp.0069 · Cited by 3
Residual Cardiovascular Risk Factors in Dyslipidemia
Nguyen, V. S., Tran, X. T., Vo, T. D., & Le, Q. T. C. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100046 · Cited by 3
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_10 · Cited by 3
Genetische Erkrankungen des Lipidstoffwechsels
März, W., Beil, F.-U., & Dieplinger, H. (2022) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1516-2541 · Cited by 3
Significance of traditional herbal medicine for dyslipidemia.
Kang, Y., Kim, Y.-J., & Kim, K. (2023) · PubMed Central · Cited by 3
LDL receptor traffic: in the fast lane
Kleber, M. E., Delgado, G. E., & März, W. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz866 · Cited by 3
Cholesteryl Hemiazelate Induces Lysosome Dysfunction and Exocytosis in MacrophagesPreprint
Domingues, N. S., Calado, R. D. A., Brito, P. H., Matthiesen, R., Ramalho, J., Soares, M. I. L., Pereira, T., Oliveira, L. B., Vicente, J. R., Wong, L. H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.05.422575 · Cited by 3
Apolipoprotein B Secretion Assay from Primary Hepatocytes
Wang, Y., Li, X., Huang, R., Chen, X.-W., & Wang, X. (2024) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4982 · Cited by 2
Lis, P., Lis, A. E., Kaźmierski, W., Jurek, J., Ziomek, M., Kocur, K., Ziobro, A., & Camlet, K. (2024) · Prospects in Pharmaceutical Sciences · doi:10.56782/pps.241 · Cited by 3
Trans 10, cis 12-conjugated linoleic acid alleviates vascular fibrosis in obese mice
Yu, S., Rao, Y., Lu, J., Li, J., Wang, B., & Gou, K. (2025) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2025.102669 · Cited by 2
Squier, K., Waugh, C., Callow, J., Patola, W. B., Hunt, M. A., Brunham, L. R., Jakobi, J. M., & Scott, A. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-08430-4 · Cited by 2
Zou, H., Liao, S., Lu, R., Pang, Y., Li, J., & Zhang, J. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106277 · Cited by 2
Deng, Z., Yang, Z., Li, L., Zeng, G., Meng, Z., & Liu, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-96855-1 · Cited by 4
Atherosclerosis Is a Global No. 1 Killer
Watanabe, T., & Fan, J. (2025) · Springer eBooks · doi:10.1007/978-981-96-3675-4_1 · Cited by 2
The Functional Interaction Between PRDM16 and the SREBP Pathway Controls Lipid Metabolism
Mahmood, H. M., Bengoechea-Alonso, M. T., Al-Ansari, D. E., Machaca, K., & Ericsson, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110246 · Cited by 3
Wang, Y., Sun, J., Xue, L., Sun, Y., Zhang, K., Fan, M., Qian, H., Li, Y., & Wang, L. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70291 · Cited by 2
Roth, K., Yang, Z., Agarwal, M., Gurdziel, K., & Petriello, M. C. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117683 · Cited by 2
NPC1 trafficking via VPS41-dependent LAMP carriers regulates endosomal cholesterol homeostasis
Ndoj, K., Tantucci, M., Sanzà, P., Zubak, K., Marodin, G., Kingma, J., Snijder, F., Veenendaal, T., Kober, D. L., Zelcer, N., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2521979122 · Cited by 2
Advances in cholesterol and lipoproteins detection for healthcare: A review
Giaretta, J., Fardindoost, S., Abdi, A., Yazdani, K., Yin, L., Farajikhah, S., Hoorfar, M., & Dehghani, F. (2026) · Open Research (University of Surrey) · doi:10.1002/viw.20250169 · Cited by 2
High-cholesterol-load-triggered pyroptosis of gingival fibroblasts promotes periodontitis
Wang, Z., Li, Y., Chen, H., Zhang, X., Zhang, Y., Gao, X., Luo, J., Song, J., & Zhou, Z. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116259 · Cited by 2
Endoluminal Catheter Pulsed Field Ablation for the Treatment of Atherosclerotic Vascular Disease
Salameh, Z. S., Jacobs, E. J., & Davalos, R. V. (2026) · Annals of Biomedical Engineering · doi:10.1007/s10439-026-04044-6 · Cited by 3
Zhang, H., Chen, J., Chen, Y., Yang, Z., Yang, Q., Ye, B., Li, D., & Gan, W. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345316 · Cited by 2
Pleiotropic Cholesterol Signaling in Drosophila and Mammalian Systems
Kang, Y., Atif, M., & Lee, Y. (2026) · Metabolites · doi:10.3390/metabo16040220 · Cited by 2
Mauriello, A., Falco, A. D., Correra, A., D’Andrea, A., Giallauria, F., Giordano, A., & Russo, V. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01414-2 · Cited by 2
Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover
Feng, X., Zhang, S., Wang, Y., Kurlagunda, T., Sit, A., Jaishankar, P., Yang, P., Sakane, S., Park, S. Y., Wisessaowapak, C., et al. (2026) · Nature · doi:10.1038/s41586-026-10697-z · Cited by 2
Fricke, U., Hein, L., & Schwabe, U. (2016) · Springer eBooks · doi:10.1007/978-3-662-50351-5_3 · Cited by 1
Are current dietary guidelines relevant to subjects on cholesterol-lowering drugs?
Salter, A. M. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119000685 · Cited by 2
Distribution of Psychotropic Drugs Into Lipoproteins
Serkland, T. T., Schjøtt, J. D., Berg, J. A., Herfindal, L., Riedel, B., & Skrede, S. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000660 · Cited by 2
Papel de los lípidos en la ateroesclerosis
Civeira, F., Marco-Benedí, V., & Cenarro, A. (2020) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(20)30023-6 · Cited by 5
PCSK9 and lipid metabolism and atherosclerosis: animal models
Getz, G. S., & Reardon, C. A. (2021) · Vessel Plus · doi:10.20517/2574-1209.2020.70 · Cited by 3
Zhang, Y., Zhao, X.-Q., Ding, X., Chen, H., Li, H., & Li, W. (2022) · Angiology · doi:10.1177/00033197221075861 · Cited by 2
Li, Y., Sun, M., Li, R., Dou, M., Dong, H., Xue, L., & Sun, G. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.23-45 · Cited by 4
Association of statins with nonalcoholic fatty liver disease in patients with diabetes
Shah, R., Kong, A., de Melo, S. W., Jr., Boktor, M., Henriquez, R., Mandalia, A. B., Samant, H. V., Álvarez, C. A., & Mansi, I. A. (2024) · Journal of Investigative Medicine · doi:10.1177/10815589241248076 · Cited by 2
The Potential Role of Tocotrienols Against Cardiovascular Diseases
Yeganehjoo, H., Zamani, N., Chitkara, S., & Shah, A. K. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-55489-6_7 · Cited by 3
Zhou, W., Feng, W., Chang, J., Hu, J., Li, F., Hu, K., Jiao, J., Xue, X., Lan, T., Wan, W., et al. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004388 · Cited by 2
Abdirashid, M., Barbero, U., Cavallino, C., Maltese, L., Bacci, E., Reale, D., Marengo, G., Benedictis, M. D., Rametta, F., & Ugo, F. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11070224 · Cited by 2
Understanding lipidomics associations and the lipoprotein-related caveats in population epidemiology
Zhao, S., Ohukainen, P., Kettunen, J., Järvelin, M., Kähönen, M. A. P., Lehtimäki, T. J., Viikari, J., Raitakari, O. T., Mäkinen, V., & Ala‐Korpela, M. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae445 · Cited by 2
Fadahunsi, O. S., & Olorunnisola, O. S. (2024) · The Journal of Basic and Applied Zoology · doi:10.1186/s41936-024-00399-1 · Cited by 2
Zhao, X., Ni, L., Kubo, M., Matsuto, M., Sakurai, H., Shimizu, M., Takahashi, Y., Sato, R., & Yamauchi, Y. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00714.2024 · Cited by 2
Zhou, M., Zhang, X., Guo, X., Duan, J., Zhang, H., Liu, X., Liu, T., Chen, K., & Liu, C. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04849-8 · Cited by 2
EGF‐artige und andere disulfidreiche Mikrodomänen als therapeutische Molekülgerüste
Tombling, B. J., Wang, C. K. L., & Craik, D. J. (2019) · Angewandte Chemie · doi:10.1002/ange.201913809 · Cited by 2
Chua, Y.-A., Nazli, S. A., Rosman, A., Kasim, S. S., Ibrahim, K. S., Radzi, A. B. M., Kasim, N. A. M., & Nawawi, H. M. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63389 · Cited by 2
Müller‐Wieland, D., & Marx, N. (2016) · Herz · doi:10.1007/s00059-016-4434-4 · Cited by 2
Blankenberg, S., & Zeller, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42880-4.00009-1 · Cited by 2
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Madasamy, S., Liu, D., Lundry, J., Alderete, B. E., Kong, R., Robinson, J. P., Wu, A. H. B., & Amento, E. P. (2017) · Journal of Visualized Experiments · doi:10.3791/56596 · Cited by 2
Metabolism of Fat, Carbohydrate, and Nucleic Acids
Litwack, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-383864-3.00014-4 · Cited by 2
Cardiovascular, Cerebrovascular, and Renovascular Consequences of Ageing May Be Challenged
Strandberg, T. E. (2018) · Practical issues in geriatrics · doi:10.1007/978-3-319-96529-1_7 · Cited by 2
Midlife risk factors of diseases and geriatric syndromes
Strandberg, T. E. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198701590.003.0163 · Cited by 2
Suchánek, P., Lánská, V., Stávek, P., & Hubacek, J. A. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/129574 · Cited by 2
Arutyunov, G. P., Arutyunov, A. G., Ageev, F. T., & Фофанова, Т. В. (2021) · JMIR Research Protocols · doi:10.2196/29061 · Cited by 2
Metabolism of Fat, Carbohydrate, and Nucleic Acids
Litwack, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85718-5.00002-9 · Cited by 2
The Significance of Apolipoprotein-A in the Long-Term Death of Patients with STEMI
Lin, G., Chen, W., Dai, C., & Xu, K. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/5941117 · Cited by 2
RetractedNaik, A. A., & Sivaramakrishnan, V. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110808 · Cited by 2
Rajasekaran, S., Santhaseela, A. R., Ragunathan, S., Venkataraman, S., & Jayavelu, T. (2022) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-022-01123-y · Cited by 2
A scoping review on natural cholesterol lowering supplements sold in South African pharmacies
Lee, H. B., Khan, R., Vally, M., & Orchard, A. (2024) · Health SA Gesondheid · doi:10.4102/hsag.v29i0.2299 · Cited by 2
New lipid therapies: PCSK9 inhibitors
Meah, F. A., Basit, A., Mazhari, A., Emanuele, M. A., & Emanuele, N. (2016) · Journal of Clinical and Translational Endocrinology Case Reports · doi:10.1016/j.jecr.2016.07.001 · Cited by 2
Treatment of atherogenic dyslipidemia: modern principles and new possibilities
Bubnova, M. G. (2017) · Cardiosomatics · doi:10.26442/2221-7185_8.2.51-58 · Cited by 2
Association of Non-LDL Indices with Recurrent Stroke Risk while on Lipid-Modifying Therapy
Park, J., & Ovbiagele, B. I. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.49304 · Cited by 2
Васильченко, В. С., Dunaevskaya, O., Korol, L., Кучменко, О. Б., & Stepanova, N. (2019) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs04.06.321 · Cited by 2
Giesecke, Y., Soete, S., Mackinnon, K., Tsiaras, T., Ward, M., Althobaiti, M., Süveges, T., Lucocq, J. E., McKenna, S. J., & Lucocq, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176373 · Cited by 2
Wei, G., Xue, L., Zhu, Y.-D., Qian, X., Zou, L., Jin, Q., Wang, D., & Ge, G. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22699 · Cited by 2
Lu, H., Zhang, J., Chen, Y. E., & Garcia-Barrio, M. T. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07175-1 · Cited by 2
Pathophysiologische Prinzipien von Dyslipoproteinämien
Müller‐Wieland, D., Merkel, M., Verket, M., März, W., & von Eckardstein, A. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1516-2441 · Cited by 2
Péptidos bioactivos de globulinas de amaranto
Nardo, A. E. (2017) · doi:10.35537/10915/60636 · Cited by 2
Wu, S., & Näär, A. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/441303 · Cited by 2
Foest, D., Knodel, A., Ahrends, R., Coman, C., Franzke, J., & Brandt, S. (2021) · doi:10.33774/chemrxiv-2021-dzzmj · Cited by 2
Manganese ions acts as a messenger to regulate serum lipid levels
Sun, H., Chen, S., & Liu, J. (2023) · Metabolism Open · doi:10.1016/j.metop.2023.100268 · Cited by 2
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Goldstein, Joseph L.
- Brown, Michael S.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 161
- Issue
- 1
- Pages
- 161-172
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4525717
- OpenAlex
- W2160347316
- Cited by
- 1,233
- References
- 115
- Citations by year
- 2026: 101 · 2025: 134 · 2024: 117 · 2023: 121 · 2022: 136 · 2021: 150 · 2020: 116 · 2019: 105 · 2018: 87 · 2017: 84 · 2016: 61 · 2015: 19
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Regeneron Pharmaceuticals
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- cholesterol, coronary artery disease, low-density lipoprotein, LDL receptor, LDLR mutations, familial hypercholesterolemia, statins, lipid-lowering therapy, atherosclerosis
- MeSH terms
- Animals, Cardiovascular Diseases, Cholesterol, Coronary Vessels, Dietary Fats, Humans, Receptors, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
